- Home
- IOBT vs HYPR Comparison
IOBT vs HYPR Comparison
Compare IOBT & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOBT
- HYPR
- Stock Information
- Founded
- IOBT 2014
- HYPR 2014
- Country
- IOBT Denmark
- HYPR United States
- Employees
- IOBT 80
- HYPR N/A
- Industry
- IOBT Biotechnology: Pharmaceutical Preparations
- HYPR Medical Specialities
- Sector
- IOBT Health Care
- HYPR Health Care
- Exchange
- IOBT Nasdaq
- HYPR Nasdaq
- Market Cap
- IOBT 56.5M
- HYPR 54.6M
- IPO Year
- IOBT 2021
- HYPR N/A
- Fundamental
- Price
- IOBT $0.86
- HYPR $0.70
- Analyst Decision
- IOBT Strong Buy
- HYPR Strong Buy
- Analyst Count
- IOBT 3
- HYPR 3
- Target Price
- IOBT $9.33
- HYPR $1.33
- AVG Volume (30 Days)
- IOBT 266.2K
- HYPR 462.5K
- Earning Date
- IOBT 05-13-2025
- HYPR 05-12-2025
- Dividend Yield
- IOBT N/A
- HYPR N/A
- EPS Growth
- IOBT N/A
- HYPR N/A
- EPS
- IOBT N/A
- HYPR N/A
- Revenue
- IOBT N/A
- HYPR $12,890,000.00
- Revenue This Year
- IOBT N/A
- HYPR $24.00
- Revenue Next Year
- IOBT N/A
- HYPR $28.70
- P/E Ratio
- IOBT N/A
- HYPR N/A
- Revenue Growth
- IOBT N/A
- HYPR 16.84
- 52 Week Low
- IOBT $0.66
- HYPR $0.58
- 52 Week High
- IOBT $1.79
- HYPR $1.90
- Technical
- Relative Strength Index (RSI)
- IOBT 41.66
- HYPR 43.10
- Support Level
- IOBT $0.85
- HYPR $0.58
- Resistance Level
- IOBT $0.94
- HYPR $0.76
- Average True Range (ATR)
- IOBT 0.10
- HYPR 0.07
- MACD
- IOBT -0.02
- HYPR 0.01
- Stochastic Oscillator
- IOBT 8.13
- HYPR 55.45
About IOBT IO Biotech Inc.
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
About HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.